BA
REGN icon

Boston Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Boston Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-855
Closed -$268K – 631
2019
Q2 		$268K Sell
855
-10,688
-93% -$3.56M 0.01% 584
2019
Q1 		$4.74M Sell
11,543
-5,165
-31% -$2.13M 0.24% 114
2018
Q4 		$6.24M Buy
16,708
+8,710
+109% +$3.19M 0.36% 67
2018
Q3 		$3.23M Buy
7,998
+7,267
+994% +$2.77M 0.14% 230
2018
Q2 		$252K Sell
731
-5,985
-89% -$1.87M 0.01% 603
2018
Q1 		$2.31M Buy
6,716
+1,810
+37% +$630K 0.06% 263
2017
Q4 		$1.84M Sell
4,906
-360
-7% -$146K 0.04% 288
2017
Q3 		$2.35M Sell
5,266
-430
-8% -$205K 0.05% 277
2017
Q2 		$2.8M Buy
5,696
+465
+9% +$203K 0.06% 274
2017
Q1 		$2.03M Sell
5,231
-1,921
-27% -$712K 0.05% 284
2016
Q4 		$2.63M Sell
7,152
-325
-4% -$124K 0.06% 281
2016
Q3 		$3.01M Buy
7,477
+80
+1% +$32.1K 0.07% 251
2016
Q2 		$2.58M Buy
7,397
+1,095
+17% +$422K 0.06% 258
2016
Q1 		$2.27M Buy
6,302
+303
+5% +$125K 0.06% 255
2015
Q4 		$3.26M Buy
5,999
+518
+9% +$281K 0.08% 236
2015
Q3 		$2.55M Sell
5,481
-947
-15% -$509K 0.1% 239
2015
Q2 		$3.28M Sell
6,428
-78
-1% -$38.1K 0.14% 172
2015
Q1 		$2.94M Buy
6,506
+3,585
+123% +$1.52M 0.12% 191
2014
Q4 		$1.2M Buy
2,921
+125
+4% +$49.2K 0.05% 246
2014
Q3 		$1.01M Buy
2,796
+5
+0.2% +$1.68K 0.04% 273
2014
Q2 		$788K Sell
2,791
-74
-3% -$21.9K 0.03% 304
2014
Q1 		$860K Buy
2,865
+195
+7% +$60.1K 0.04% 284
2013
Q4 		$735K Sell
2,670
-7,995
-75% -$2.3M 0.04% 302
2013
Q3 		$3.34M Buy
10,665
+85
+0.8% +$22.4K 0.18% 134
2013
Q2 		$2.38M Buy
+10,580
New +$2.46M 0.11% 155

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Boston Advisors's REGN Position: Q3 2019 in Review

Boston Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q3 2019, closing a stake of 855 shares — an estimated $268K sold.

Boston Advisors first reported a position in REGN in Q2 2013 and held it in 25 quarters. The position peaked at $6.24M in Q4 2018. 633 funds tracked by Wall St. Rank hold REGN as of Q3 2019.

  • Boston Advisors reported no remaining Regeneron Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Boston Advisors sold 855 Regeneron Pharmaceuticals shares in Q3 2019, an estimated $268K.
  • Boston Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 25 quarters.
  • Boston Advisors's Regeneron Pharmaceuticals position peaked at $6.24M in Q4 2018.
  • 633 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.